349 related articles for article (PubMed ID: 22267597)
21. Targeting Liver Cancer and Associated Pathologies in Mice with a Mitochondrial VDAC1-Based Peptide.
Pittala S; Krelin Y; Shoshan-Barmatz V
Neoplasia; 2018 Jun; 20(6):594-609. PubMed ID: 29747160
[TBL] [Abstract][Full Text] [Related]
22. Diethylnitrosamine-induced hepatocarcinogenesis is suppressed in lecithin:retinol acyltransferase-deficient mice primarily through retinoid actions immediately after carcinogen administration.
Shirakami Y; Gottesman ME; Blaner WS
Carcinogenesis; 2012 Feb; 33(2):268-74. PubMed ID: 22116467
[TBL] [Abstract][Full Text] [Related]
23. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.
Homma S; Komita H; Sagawa Y; Ohno T; Toda G
Immunology; 2005 Aug; 115(4):451-61. PubMed ID: 16011514
[TBL] [Abstract][Full Text] [Related]
24. β-Catenin loss in hepatocytes promotes hepatocellular cancer after diethylnitrosamine and phenobarbital administration to mice.
Awuah PK; Rhieu BH; Singh S; Misse A; Monga SP
PLoS One; 2012; 7(6):e39771. PubMed ID: 22761897
[TBL] [Abstract][Full Text] [Related]
25. Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis.
Teoh N; Pyakurel P; Dan YY; Swisshelm K; Hou J; Mitchell C; Fausto N; Gu Y; Farrell G
Gastroenterology; 2010 Mar; 138(3):1155-65.e1-2. PubMed ID: 19919837
[TBL] [Abstract][Full Text] [Related]
26. Transcriptomic analysis of a transgenic zebrafish hepatocellular carcinoma model reveals a prominent role of immune responses in tumour progression and regression.
Li Z; Luo H; Li C; Huo X; Yan C; Huang X; Al-Haddawi M; Mathavan S; Gong Z
Int J Cancer; 2014 Oct; 135(7):1564-73. PubMed ID: 24550086
[TBL] [Abstract][Full Text] [Related]
27. Superoxide deficiency attenuates promotion of hepatocarcinogenesis by cytotoxicity in NADPH oxidase knockout mice.
Parzefall W; Freiler C; Lorenz O; Koudelka H; Riegler T; Nejabat M; Kainzbauer E; Grasl-Kraupp B; Schulte-Hermann R
Arch Toxicol; 2015 Aug; 89(8):1383-93. PubMed ID: 25182417
[TBL] [Abstract][Full Text] [Related]
28. Growth arrest and DNA damage-inducible protein (GADD34) enhanced liver inflammation and tumorigenesis in a diethylnitrosamine (DEN)-treated murine model.
Chen N; Nishio N; Ito S; Tanaka Y; Sun Y; Isobe K
Cancer Immunol Immunother; 2015 Jun; 64(6):777-89. PubMed ID: 25832002
[TBL] [Abstract][Full Text] [Related]
29. [Differentially expressed proteins in the precancerous stage of rat hepatocarcinogenesis induced by diethylnitrosamine].
Liang HJ; Wei W; Kang XN; Guo K; Cao J; Su JJ; Yang C; Ou C; Li Y; Liu YK
Zhonghua Gan Zang Bing Za Zhi; 2009 Sep; 17(9):669-74. PubMed ID: 19785954
[TBL] [Abstract][Full Text] [Related]
30. Interferon-gamma-mediated hepatocarcinogenesis in mice treated with diethylnitrosamine.
Matsuda M; Nakamoto Y; Suzuki S; Kurata T; Kaneko S
Lab Invest; 2005 May; 85(5):655-63. PubMed ID: 15765122
[TBL] [Abstract][Full Text] [Related]
31. NFκB1 is a suppressor of neutrophil-driven hepatocellular carcinoma.
Wilson CL; Jurk D; Fullard N; Banks P; Page A; Luli S; Elsharkawy AM; Gieling RG; Chakraborty JB; Fox C; Richardson C; Callaghan K; Blair GE; Fox N; Lagnado A; Passos JF; Moore AJ; Smith GR; Tiniakos DG; Mann J; Oakley F; Mann DA
Nat Commun; 2015 Apr; 6():6818. PubMed ID: 25879839
[TBL] [Abstract][Full Text] [Related]
32. Essential contribution of a chemokine, CCL3, and its receptor, CCR1, to hepatocellular carcinoma progression.
Yang X; Lu P; Fujii C; Nakamoto Y; Gao JL; Kaneko S; Murphy PM; Mukaida N
Int J Cancer; 2006 Apr; 118(8):1869-76. PubMed ID: 16284949
[TBL] [Abstract][Full Text] [Related]
33. FGF19/FGFR4-mediated elevation of ETV4 facilitates hepatocellular carcinoma metastasis by upregulating PD-L1 and CCL2.
Xie M; Lin Z; Ji X; Luo X; Zhang Z; Sun M; Chen X; Zhang B; Liang H; Liu D; Feng Y; Wang Y; Li Y; Liu B; Huang W; Xia L
J Hepatol; 2023 Jul; 79(1):109-125. PubMed ID: 36907560
[TBL] [Abstract][Full Text] [Related]
34. Cell proliferation and regulation of negative growth factors in mouse liver foci.
Moser GJ; Wolf DC; Harden R; Standeven AM; Mills J; Jirtle RL; Goldsworthy TL
Carcinogenesis; 1996 Sep; 17(9):1835-40. PubMed ID: 8824503
[TBL] [Abstract][Full Text] [Related]
35. beta-Naphthoflavone enhances oxidative stress responses and the induction of preneoplastic lesions in a diethylnitrosamine-initiated hepatocarcinogenesis model in partially hepatectomized rats.
Dewa Y; Nishimura J; Muguruma M; Jin M; Saegusa Y; Okamura T; Tasaki M; Umemura T; Mitsumori K
Toxicology; 2008 Feb; 244(2-3):179-89. PubMed ID: 18164116
[TBL] [Abstract][Full Text] [Related]
36. Cytokeratin 7/19 expression in N-diethylnitrosamine-induced mouse hepatocellular lesions: implications for histogenesis.
Santos NP; Oliveira PA; Arantes-Rodrigues R; Faustino-Rocha AI; Colaço A; Lopes C; Gil da Costa RM
Int J Exp Pathol; 2014 Jun; 95(3):191-8. PubMed ID: 24730441
[TBL] [Abstract][Full Text] [Related]
37. Rac1 promotes diethylnitrosamine (DEN)-induced formation of liver tumors.
Bopp A; Wartlick F; Henninger C; Schwarz M; Kaina B; Fritz G
Carcinogenesis; 2015 Mar; 36(3):378-89. PubMed ID: 25556150
[TBL] [Abstract][Full Text] [Related]
38. Production of liver preneoplasia and gallbladder agenesis in turkey fetuses administered diethylnitrosamine.
Williams GM; Brunnemann KD; Iatropoulos MJ; Smart DJ; Enzmann HG
Arch Toxicol; 2011 Jun; 85(6):681-7. PubMed ID: 20981410
[TBL] [Abstract][Full Text] [Related]
39. The N-nitrosodiethylamine mouse model: sketching a timeline of evolution of chemically-induced hepatic lesions.
Da Costa RM; Paula-Santos N; Rocha AF; Colaço A; Lopes C; Oliveira PA
Anticancer Res; 2014 Dec; 34(12):7029-37. PubMed ID: 25503129
[TBL] [Abstract][Full Text] [Related]
40. Gene expression analysis on the dicyclanil-induced hepatocellular tumors in mice.
Moto M; Okamura M; Muguruma M; Ito T; Jin M; Kashida Y; Mitsumori K
Toxicol Pathol; 2006; 34(6):744-51. PubMed ID: 17162532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
